. Chronic and acute variables may precipitate dysphonia. These include occupational vocal demands, medications, health problems, environment, physical trauma, and lifestyle choices. Dysphonia is as disruptive to quality of life as angina, sciatica, and chronic sinusitis (Benninger, Ahuja, Gardner, & Grywalski, 1998) . The communicative problems associated with dysphonia can lead to social withdrawal, occupational handicaps, and depression (E. Smith et al., 1996) .
Voice disorders are a widespread and significant problem. Estimates of prevalence range from 3% to 7% of the general population (Healy, Ackerman, Chappell, Perrin, & Stormer, 1981) . Individuals with heavy occupational voice use, a significant risk factor for dysphonia, may comprise from 5%-10% of the U.S. workforce (Titze, Lemke, & Montequin, 1997) . The largest epidemiologic study of the prevalence of voice disorders in the United States (Roy et al., 2004) revealed that approximately 43% of adults surveyed experienced voice problems at some point during their life. Approximately 23% of those individuals visited a physician or speech-language pathologist for treatment for dysphonia. The cost of untreated voice disorders total billions of dollars in treatment and lost productivity costs (Ramig & Verdolini, 1998) . In teachers alone, the cost of dysphonia approaches $2.67 billion annually in the United States (Verdolini & Ramig, 2001 ).
The overall goal for the patient with dysphonia is optimal long-term voice quality and communication function with minimal recurrence. Diagnosis and treatment should be both efficient and effective. Voice therapy is an integral component of intervention and contributes to both its efficacy and efficiency. Evidence from clinical trials documents the efficacy of voice therapy for a spectrum of voice disorders in both adults and children (Bassiouny, 1998; Boone, 1974; MacKenzie Millar, Wilson, Sellars, & Deary, 2001; Roy et al., 2001; Sellars, Carding, Deary, MacKenzie, & Wilson, 2002; Speyer, Wieneke, & Dejonckere, 2004; Verdolini-Marston, Burke, Lessac, Glaze, & Caldwell, 1995; Xu, Ikeda, & Komiyama, 1991) . Even in patients with a long history of dysphonia, voice therapy can be highly effective (Speyer et al., 2004) . Efficiency includes cost-effective and prompt intervention provided over a time period most suitable for achieving optimal outcome.
Voice therapy is the treatment of choice for muscle tension dysphonia and there is evidence to support its utility in these cases (Andrews, Warner, & Stewart, 1986; Carding, Horsley, & Docherty, 1999; Fex, Fex, Shiromoto, & Hirano, 1994; Kitzing & Akerlund, 1993; Maryn, De Bodt, & Van Cauwenberge, 2003; Roy, Bless, Heisey, & Ford, 1997 Gay, & Wood, 1987; Stemple, Lee, D'Amicco, & Pickup, 1994) .
Benign vocal fold lesions are a common cause of dysphonia (Gould, Rubin, & Yanagisawa, 1995) . Most laryngologists consider voice therapy, often together with medical management, the initial treatment of choice for benign lesions (Anderson & Sataloff, 2002; Garrett & Ossoff, 2000; Pedersen, Beranova, & Moller, 2004; Sulica & Behrman, 2003) . Many studies have documented excellent outcomes after voice therapy in patients with a variety of benign lesions (Blood, 1994; Gordon, Pearson, Paton, & Montgomery, 1997; Holmberg, Hillman, Hammarberg, Sodersten, & Doyle, 2001; Lancer, Syder, Jones, & Le Boutillier, 1988; McCrory, 2001; Murry & Woodson, 1992; S. Smith & Thyme, 1976; Speyer et al., 2002; Verdolini-Marston et al., 1995; Ylitalo & Hammarberg, 2000) . Increasingly, otolaryngologists are using response to voice therapy to help differentiate among benign mucosal lesions, inform the treatment decision for surgery, and optimize surgical outcome. In cases in which surgery is necessary, pre-and postoperative voice therapy may shorten the postoperative recovery time, allowing faster return to work and limiting scar tissue and permanent dysphonia (Woo, Casper, Colton, & Brewer, 1994) .
Most laryngologists consider voice therapy essential for patients with unilateral vocal fold paralysis as definitive treatment or as adjunctive to surgery (Benninger et al., 1994) . Evidence suggests that preoperative voice therapy improves voice outcomes for greater than 50% of patients with unilateral vocal fold paralysis and may render surgery unnecessary (Heuer et al., 1997) . In other neurological-based dysphonia, such as Parkinson's disease, voice therapy has yielded significant improvement in overall communication (de Angelis et al., 1997; Ramig, Countryman, O'Brien, Hoehn, & Thompson, 1996; M. E. Smith, Ramig, Dromey, Perez, & Samandari, 1995; Spielman, Borod, & Ramig, 2003) .
In conclusion, research data and expert clinical experience support the use of voice therapy in the management of patients with acute and chronic voice disorders. Voice therapy contributes to increased effectiveness and efficiency in the treatment of voice disorders. When surgery is necessary, adjuvant voice therapy can improve surgical outcomes, prevent additional injury, and limit additional treatment costs.
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